V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006161 | 200011456 | 1.71 | 110.95 | null | 2021-01-10 | 2021-01-26 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101752441 |
| 200006162 | 200011457 | null | null | null | null | 2019-01-26 | null | null | null | IMATINIB | 101767241 |
| 200006164 | 200011459 | null | 92 | Palliative (P) | 2017-10-29 | 2018-02-22 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101186243 |
| 200006165 | 200011460 | null | null | null | null | 2018-09-23 | null | null | null | DOCETAXEL | 101058282 |
| 200006166 | 200011461 | null | null | null | null | 2020-01-20 | null | null | null | LIPOSOMAL DOXORUBICIN | 101297040 |
| 200006167 | 200011462 | 1.71 | null | null | 2019-07-29 | 2019-08-04 | DABRAFENIB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100494113 |
| 200006169 | 200011464 | 1.59 | 62 | Palliative (P) | 2018-11-30 | 2018-12-05 | DABRAFENIB | 02 | N | DABRAFENIB | 100689510 |
| 200006170 | 200011465 | 0 | 0 | 03 | null | 2019-01-26 | Ipilimumab | null | null | IPILIMUMAB | 101779818 |
| 200006171 | 200011466 | 1.72 | 86.9 | Palliative (P) | 2018-09-13 | 2018-09-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101667544 |
| 200006173 | 200011468 | 1.76 | 69.6 | Palliative (P) | 2018-02-17 | 2018-10-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100188177 |
| 200006174 | 200011469 | null | 47 | Palliative (P) | 2017-04-04 | 2017-04-10 | Rituximab | 02 | null | IPILIMUMAB | 101661754 |
| 200006175 | 200011470 | 1.7 | 61 | Palliative (P) | 2017-11-20 | 2018-04-02 | DABRAFENIB | 02 | null | DABRAFENIB | 100285165 |
| 200006176 | 200011471 | 1.76 | 95.5 | null | 2017-08-16 | 2017-08-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100273925 |
| 200006178 | 200011473 | 1.7 | 95.6 | Palliative (P) | 2018-08-30 | 2018-09-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100194693 |
| 200006179 | 200011474 | 1.78 | 144.8 | Palliative (P) | 2017-12-08 | 2017-12-10 | Ipilimumab | 02 | null | IPILIMUMAB | 100554040 |
| 200006182 | 200011476 | null | 95.5 | null | 2016-12-13 | 2016-12-13 | Vemurafenib | N | null | DABRAFENIB | 101367118 |
| 200006185 | 200011479 | 1.77 | 73 | null | 2016-02-28 | 2016-07-26 | Ipilimumab | null | null | IPILIMUMAB | 100689409 |
| 200006186 | 200011480 | null | 87.1 | Palliative (P) | 2021-05-29 | 2021-06-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101017131 |
| 200006187 | 200011481 | 1.7 | 102 | Palliative (P) | 2017-10-29 | 2017-11-19 | Ipilimumab | 02 | null | IPILIMUMAB | 101692893 |
| 200006188 | 200011482 | 1.68 | 87.35 | 02 | 2015-03-17 | 2015-03-21 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100939256 |
| 200006189 | 200011483 | 1.71 | 70.8 | null | 2020-12-06 | 2020-12-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100245304 |
| 200006190 | 200011484 | 1.81 | 88.6 | Palliative (P) | 2021-06-19 | 2021-06-28 | DABRAFENIB | 02 | null | DABRAFENIB | 100168781 |
| 200006195 | 200011488 | 1.85 | 90 | Palliative (P) | null | 2019-06-13 | null | null | null | TALIMOGENE LAHERPAREPVEC | 100831750 |
| 200006196 | 200011489 | 1.7 | 111 | 03 | 2021-07-30 | 2021-12-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101740734 |
| 200006197 | 200011490 | 1.84 | 70 | null | 2021-04-15 | 2021-04-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100385307 |
| 200006199 | 200011492 | 1.66 | 80.3 | Palliative (P) | 2018-09-20 | 2018-09-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101848029 |
| 200006200 | 200011493 | 1.57 | 87 | Palliative (P) | 2018-01-03 | 2018-01-30 | IPILIMUMAB + NIVOLUMAB | N | null | DABRAFENIB | 101803224 |
| 200006207 | 200011497 | null | 86.9 | null | 2020-03-22 | 2020-04-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100647769 |
| 200006209 | 200011498 | 1.66 | 67.25 | Palliative (P) | 2016-09-19 | 2016-10-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100639488 |
| 200006210 | 200011499 | 1.82 | 76.3 | null | null | 2018-09-28 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100609079 |
| 200006212 | 200011501 | 1.7 | 117.8 | 03 | null | 2019-02-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101775926 |
| 200006214 | 200011503 | 1.65 | 78.4 | Palliative (P) | 2018-09-18 | 2018-11-10 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100300457 |
| 200006215 | 200011504 | 1.64 | 87.3 | Palliative (P) | 2017-08-27 | 2017-08-31 | Trial Unspecified | N | null | DABRAFENIB | 101491202 |
| 200006216 | 200011505 | 0 | 0 | Palliative (P) | 2016-04-12 | 2016-04-27 | null | N | null | IPILIMUMAB | 100902851 |
| 200006218 | 200011507 | null | 95.2 | Palliative (P) | null | 2020-06-26 | null | null | null | CARBOPLATIN + DOCETAXEL | 100787107 |
| 200006219 | 200011508 | 1.63 | 126 | Adjuvant (A) | 2019-07-06 | 2019-09-18 | DABRAFENIB | 02 | null | DABRAFENIB | 100687233 |
| 200006225 | 200011514 | 1.74 | 86 | Palliative (P) | 2021-08-31 | 2021-09-20 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100866049 |
| 200006226 | 200011515 | 1.86 | 52 | Palliative (P) | 2017-03-07 | 2017-03-07 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100274789 |
| 200006227 | 200011516 | 1.63 | 79.3 | Palliative (P) | 2018-12-18 | 2018-12-29 | DABRAFENIB | 02 | N | DABRAFENIB | 101375306 |
| 200006228 | 200011517 | 1.75 | 70.8 | Palliative (P) | null | 2019-04-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100263509 |
| 200006232 | 200011520 | 1.72 | 69.05 | Palliative (P) | 2018-06-22 | 2019-06-23 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101045589 |
| 200006233 | 200011521 | 0 | 0 | Palliative (P) | 2019-11-23 | 2019-12-14 | DABRAFENIB | 02 | null | DABRAFENIB | 101513242 |
| 200006234 | 200011522 | 1.75 | 74.9 | null | 2015-12-28 | 2018-08-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100829200 |
| 200006235 | 200011523 | 1.63 | 121.2 | Palliative (P) | 2017-02-25 | 2017-02-25 | Trial Unspecified | N | N | DABRAFENIB | 101867542 |
| 200006236 | 200011524 | 1.65 | 62 | Palliative (P) | 2018-07-13 | 2018-07-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101170715 |
| 200006237 | 200011525 | null | 72.7 | Adjuvant (A) | 2021-08-06 | 2021-08-25 | Dacarbazine | 02 | N | IPILIMUMAB | 101648682 |
| 200006238 | 200011526 | 1.81 | 90 | Adjuvant (A) | 2017-05-31 | 2017-05-31 | Enzalutamide | 02 | null | DABRAFENIB | 100440453 |
| 200006239 | 200011527 | 1.66 | 101 | Palliative (P) | 2019-10-21 | 2020-01-12 | null | 2 | N | DABRAFENIB | 100695396 |
| 200006241 | 200011529 | 1.52 | 57.65 | null | 2019-01-02 | 2019-01-17 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101596365 |
| 200006243 | 200011531 | 1.73 | 79 | Adjuvant (A) | 2016-10-30 | 2016-11-20 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101545277 |